Guidelines     MGP Ltd



Forthcoming guidance
 
Published guidance
 
Select guidance type:
Select Clinical speciality:

Date: from to

Search



Title Type Clinical speciality   Published date   Review Date
Ectopic pregnancy and miscarriage: diagnosis and initial management NICE Clinical Guideline Women's health Apr 2019 -
Certolizumab pegol for treating moderate to severe plaque psoriasis NICE Technology Appraisal Skin and wound care Apr 2019 -
Tildrakizumab for treating moderate to severe plaque psoriasis NICE Technology Appraisal Skin and wound care Apr 2019 -
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) NICE Technology Appraisal Cancer Apr 2019 -
Surgical site infections: prevention and treatment NICE Clinical Guideline Infection Apr 2019 -
Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma NICE Technology Appraisal Cancer Apr 2019 -
Specialist neonatal respiratory care for babies born preterm NICE Clinical Guideline Paediatrics Apr 2019 -
Urinary incontinence and pelvic organ prolapse in women: management NICE Clinical Guideline Women's health Apr 2019 -
Caesarean section NICE Clinical Guideline Women's health Apr 2019 -
Lung cancer: diagnosis and management NICE Clinical Guideline Cancer Mar 2019 -
Ertugliflozin as monotherapy and in dual therapy for treating type 2 diabetes NICE Technology Appraisal Diabetes Mar 2019 -
Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib NICE Technology Appraisal Cancer Mar 2019 -
Pertuzumab for adjuvant treatment of early HER2-positive breast cancer NICE Technology Appraisal Cancer Mar 2019 -
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum–based chemotherapy (terminated appraisal) NICE Technology Appraisal Cancer Mar 2019 -
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) NICE Technology Appraisal Musculoskeletal and joints Mar 2019 -
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies NICE Technology Appraisal Cancer Mar 2019 -
dasatinib (Sprycel®) All Wales Medicines Strategy Group appraisal Cancer Mar 2019 -
ataluren (Translarna®) All Wales Medicines Strategy Group appraisal Musculoskeletal and joints Mar 2019 -
Cochlear implants for children and adults with severe to profound deafness NICE Technology Appraisal Eye, ear, nose and throat Mar 2019 -
ciclosporin (Verkazia®) All Wales Medicines Strategy Group appraisal Eye, ear, nose and throat Mar 2019 -
romiplostim (Nplate®) All Wales Medicines Strategy Group appraisal Haematological conditions Mar 2019 -
Benralizumab for treating severe eosinophilic asthma NICE Technology Appraisal Respiratory Mar 2019 -
Delirium: prevention, diagnosis and management NICE Clinical Guideline Neurology Mar 2019 -
Intrapartum care for women with existing medical conditions or obstetric complications and their babies NICE Clinical Guideline Women's health Mar 2019 -
Air pollution: outdoor air quality and health NICE Quality Standard Public health Feb 2019 -
People's experience using adult social care services NICE Quality Standard Public health Feb 2019 -
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia NICE Technology Appraisal Cancer Feb 2019 -
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer NICE Technology Appraisal Cancer Feb 2019 -
Encorafenib with binimetinib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma NICE Technology Appraisal Cancer Feb 2019 -
Opioid dependence: buprenorphine prolonged-release injection (Buvidal) NICE Evidence summary Pain Feb 2019 -
Child abuse and neglect NICE Quality Standard Paediatrics Feb 2019 -
Serious eye disorders NICE Quality Standard Eye, ear, nose and throat Feb 2019 -
Sexual health NICE Quality Standard Sexual health Feb 2019 -
Antenatal care for uncomplicated pregnancies NICE Clinical Guideline Women's health Feb 2019 -
Cough (acute): antimicrobial prescribing NICE Clinical Guideline Respiratory Feb 2019 -
Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease NICE Technology Appraisal Cancer Jan 2019 -
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies NICE Technology Appraisal Cancer Jan 2019 -
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer NICE Technology Appraisal Cancer Jan 2019 -
Darvadstrocel for treating perianal fistula in Crohn's disease NICE Technology Appraisal Gastrointestinal Jan 2019 -
Regorafenib for previously treated advanced hepatocellular carcinoma NICE Technology Appraisal Cancer Jan 2019 -